 |
|
| SIDE EFFECTS OF DRUGS ANNUAL 24, 24
| |
| | |
|
|
A world-wide yearly survey of new data and trends in adverse drug reactions.
To order this title, and for more information, click here
Jeffrey K. Aronson, MA DPhil MBChB FRCP FBPharmacolS FFPM(Hon), Department of Primary Health Care, University of Oxford, Oxford, UK
Included in series
Side Effects of Drugs Annual,
Description
The Side Effects of Drugs Annual is designed to provide a critical and up-to-date account of new information related to adverse drug reactions
and interactions from the clinician's point of view.
Under the supervision of the series editors, an international team of expert
authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing
new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms
of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated
and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews,
in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader
to enter the text by drug name, adverse effect name, or drug interaction.
The current Annual is the first update of the standard
encyclopaedic work in this field, Meyler's Side Effects of Drugs,
Fourteenth Edition, which was published in December 2000.
Contents
Cumulative Index of Special Reviews.
Essay: Secrecy hiding harm: case histories from the past that inform the future (I. Palmlund).
1.
Central nervous system stimulants, drugs that suppress appetite, and drugs used in Alzheimer's disease (R.P. Sequeira).
2. Antidepressant
drugs (P.J. Cowen).
3. Lithium (J.W. Jefferson).
4. Drugs of abuse (J.K. Patel, E. Wong, A.I. Green).
5. Hypnotics and sedatives (S.
Curran, S. Musa).
6. Antipsychotic drugs (A. Carvajal, L.H. Martín Arias).
7. Antiepileptic drugs (E. Perucca).
8. Opioid analgesics
and narcotic antagonists (A.H. Ghodse, A.M. Baldacchino).
9. Anti-inflammatory and antipyretic analgesics and drugs used in gout (A.
Del Favero).
10. General anesthetics and therapeutic gases (T.G. Short, E. Hedayati).
11. Local anesthetics (S.A. Schug, D. Watson).
12. Neuromuscular blocking agents and skeletal muscle relaxants (O. Zuzan, M. Leuwer).
13. Drugs affecting autonomic functions or the
extrapyramidal system (M. Schachter).
14. Dermatological drugs, topical agents, and cosmetics (M.M. Meinardi, M. Mulder).
15. Antihistamines
(A.N. Nicholson).
16. Drugs acting on the respiratory tract (T.D. Robinson, A. Havryk, J.P. Seale).
17. Positive inotropic drugs and
drugs used in dysrhythmias (J.K. Aronson).
18. Beta-adrenoceptor antagonists and antianginal drugs (A.P. Maggioni, M.G. Franzosi, R.
Latini).
19. Drugs acting on the cerebral and peripheral circulations (R. Verhaeghe).
20. Antihypertensive drugs (F. Zannad).
21. Diuretics
(G.T. MacInnes).
22. Metals (G.B. van der Voet, F.A. de Wolff).
23. Metal antagonists (R.H.B. Meyboom).
24. Antiseptic drugs and disinfectants
(P. Magee).
25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines (T. Midtvedt).
26. Miscellaneous antibacterial
drugs (R. Walter).
27. Antifungal drugs (A.H. Groll, C.C. Chiou, T.J. Walsh).
28. Antiprotozoal drugs (C.J.M. Whitty, S. Krishna).
29. Antiviral drugs (M.N.G. Dukes).
30. Drugs used in tuberculosis and leprosy (C.J. Ellis).
31. Antihelminthic drugs (A.G.C. Bauer).
32. Vaccines (S. Dittmann).
33. Blood, blood components, plasma and plasma products (H.W. Eijkhout, W.G. van Aken).
34. Intravenous
infusions - solutions and emulsions (M.C. Allwood).
35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis (K. Peerlinck,
J. Vermylen).
36. Gastrointestinal drugs (H.J. de Silva).
37. Drugs acting on the immune system (T. Vial, J. Descotes).
38. Vitamins
(H.D. Reuter).
39. Corticotrophins, corticosteroids and prostaglandins (J. Costa, M. Farré).
40. Sex hormones and related compounds,
including hormonal contraceptives (M.N.G. Dukes).
41. Thyroid hormones and antithyroid drugs (J.A. Franklyn).
42. Insulin, glucagon,
and hypoglycemic drugs (H.M.J. Krans).
43. Miscellaneous hormones (P. Coates).
44. Drugs affecting lipid metabolism (I. Aursnes).
45. Cytostatic drugs (A. Stanley).
46. Radiological contrast agents (S.K. Morcos, P. Brown).
47. Drugs used in ocular treatment (B.C.P.
Polak).
48. Treatments used in complementary medicine (E. Ernst).
49. Miscellaneous drugs, materials, and medical devices (N.H. Choulis).
50. The WHO international Drug Monitoring Programme (S. Olsson, I.R. Edwards).
| Bibliographic details |
Hardbound, 656 pages, publication date: AUG-2001
ISBN-13: 978-0-444-50512-5
ISBN-10: 0-444-50512-1
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
USD 330
EUR 235.95
GBP 199.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 30 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company